Applied Research Center
Generated 5/10/2026
Executive Summary
Applied Research Center is a well-established, multi-specialty clinical research site based in Little Rock, Arkansas, with over 20 years of experience conducting Phase I through IV clinical trials, registries, health outcomes, and medical device studies. The center has positioned itself as a high-quality partner for sponsors, offering access to a diverse patient population in the southern United States and a track record of reliable trial execution. By focusing on a broad range of therapeutic areas, Applied Research Center provides a versatile platform for drug and device development, from early-phase safety studies to late-stage efficacy trials and post-market surveillance. The company’s long tenure and deep local relationships underscore its ability to recruit and retain patients, a critical factor in trial success. As a private entity with no disclosed funding rounds, Applied Research Center operates on a contract-based revenue model, deriving income from per-patient fees and milestone payments from sponsors. While the center is not a developer of proprietary therapies, its value lies in its operational excellence and ability to accelerate clinical timelines for its partners. The company faces competition from larger site networks and academic medical centers, but its specialized focus and proven performance help maintain a steady pipeline of studies. Going forward, Applied Research Center is well-positioned to benefit from increasing outsourced clinical trial activity, particularly as sponsors seek efficient and experienced sites to support their development programs.
Upcoming Catalysts (preview)
- Q3 2026New Strategic Partnership with a Top Pharma Sponsor65% success
- Q1 2027Expansion into a High-Growth Therapeutic Area (e.g., Gene Therapy)40% success
- TBDAward of a Large Phase III Trial with Rapid Enrollment50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)